Comparison of allogeneic stem cell transplantation results from related or unrelated donors in beta-thalassemia major
Yükleniyor...
Dosyalar
Tarih
2019
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Nature Publishing Group
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Although there have been significant improvements with conventional therapies in beta thalassemia major, hematopoietic stem cell transplantation is only curative therapy. Related donors are preferred to diminish transplant risks. In lack of identical related donor, identical unrelated donors are second best choice. In this study, thalassemia major patients transplanted from unrelated donors (MUD) were compared with thalassemic patients transplanted from relative donor (MRD) retrospectively.
Açıklama
45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT) -- MAR 24-27, 2019 -- Frankfurt, GERMANY
Anahtar Kelimeler
Kaynak
Bone Marrow Transplantation
WoS Q Değeri
Q1
Scopus Q Değeri
Cilt
54
Sayı
Künye
Aydogdu, S., Mergen, A., Aksoy, B., Cokluk, M. N., Dikme, G., Cipe, F., & Bozkurt, C. (2019). Comparison of allogeneic stem cell transplantation results from related or unrelated donors in beta-thalassemia major.
